Behrmann Lena, McComb Scott, Aguadé-Gorgorió Júlia, Huang Yun, Hermann Mario, Pelczar Pawel, Aguzzi Adriano, Bourquin Jean-Pierre, Bornhauser Beat C
Department of Oncology and Children's Research Center, University Children's Hospital Zürich, Zürich, Switzerland.
Present address: Human Health and Therapeutics, National Research Council, Ottawa, Canada.
Bio Protoc. 2017 Apr 5;7(7):e2222. doi: 10.21769/BioProtoc.2222.
CRISPR-Cas9 based knockout strategies are increasingly used to analyze gene function. However, redundancies and overlapping functions in biological signaling pathways can call for generating multi-gene knockout cells, which remains a relatively laborious process. Here we detail the application of multi-color LentiCRISPR vectors to simultaneously generate single and multiple knockouts in human cells. We provide a complete protocol, including guide RNA design, LentiCRISPR cloning, viral production and transduction, as well as strategies for sorting and screening knockout cells. The validity of the process is demonstrated by the simultaneous deletion of up to four programmed cell death mediators in leukemic cell lines and patient-derived acute lymphoblastic leukemia xenografts, in which single cell cloning is not feasible. This protocol enables any lab with access to basic cellular biology equipment, a biosafety level 2 facility and fluorescence-activated cell sorting capabilities to generate single and multi-gene knockout cell lines or primary cells efficiently within one month.
基于CRISPR-Cas9的基因敲除策略越来越多地用于分析基因功能。然而,生物信号通路中的冗余和重叠功能可能需要生成多基因敲除细胞,而这仍然是一个相对繁琐的过程。在这里,我们详细介绍了多色慢病毒CRISPR载体在人类细胞中同时产生单基因和多基因敲除的应用。我们提供了一个完整的方案,包括向导RNA设计、慢病毒CRISPR克隆、病毒生产和转导,以及分选和筛选敲除细胞的策略。通过在白血病细胞系和患者来源的急性淋巴细胞白血病异种移植中同时删除多达四种程序性细胞死亡介质,证明了该过程的有效性,在这些模型中进行单细胞克隆是不可行的。该方案使任何具备基础细胞生物学设备、生物安全2级设施和荧光激活细胞分选能力的实验室,能够在一个月内高效地生成单基因和多基因敲除细胞系或原代细胞。